U.S. Markets open in 37 hrs, 54 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 8.79 03:31 PM EDT | |
|---|---|---|
| Day High | 9.37 09:30 AM EDT |
|
| Range | 0.58 |
| Volume | 417,746 | |
|---|---|---|
| 30-Day Avg Vol | 416,000 |
|
| Difference | 0.42% |
| Market Cap | 339.48 M | |
|---|---|---|
| Mkt Cap Chg | -12.93 M |
| Shares Out | 38.05 M | |
|---|---|---|
| % Shrs Traded | 1.10% | |
| 1yr EPS Est | -0.763 |
| 52-Wk Low | 4.90 10/30/08 | |
|---|---|---|
| 52-Wk High | 10.10 1/16/09 |
|
| Range | 5.20 |
| Prev Close | 9.26 7/1/09 | |
|---|---|---|
| Today's Open | 9.22 | |
| Change | -0.43% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 3.89 M |
| Revenue (LFY) | 17.15 M | |
|---|---|---|
| Earnings (LFY) | -18.23 M | |
| Earnings (MRQ) | -9.16 M | |
| Next Earn Est | -0.255 | |
| Next Earnings | 08/10/2009 |
|
| EPS (TTM) | -0.65 | |
| 1yr EPS Growth | -17.38% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -11.00 | |
| PEG Ratio | -0.55 | |
| Return on Equity | -11.30 | |
| Beta | 1.06 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Cypress Bioscience explores the swampy waters of functional somatic syndromes, a group of chronic symptom-based disorders that are, on the whole, poorly understood. The biotech company's primary target ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.255 8/10/09 | — — |
—
—
|
| Last Quarter | 0.123 3/31/09 | -0.24 3/31/09 |
-0.363
Missed
|
| 2 Quarters Ago | -0.075 12/31/08 | -0.19 12/31/08 |
-0.115
Missed
|
| Quarterly - 03/31/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 7.86 M | 17.16 M |
| Gross Profit | 7.50 M | 16.89 M |
| Operating Income | -9.80 M | -10.38 M |
| Net Income | -9.16 M | -18.23 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts